This collection contains images from 89 non-small cell lung cancer (NSCLC) patients that were treated with surgery. For these patients pretreatment CT scans, gene expression, and clinical data are available. This dataset refers to the Lung3 dataset of the study published in Nature Communications.

 In short, this publication applies a radiomic approach to computed tomography data of 1,019 patients with lung or head-and-neck cancer. Radiomics refers to the comprehensive quantification of tumour phenotypes by applying a large number of quantitative image features. In present analysis 440 features quantifying tumour image intensity, shape and texture, were extracted.  We found that a large number of radiomic features have prognostic power in independent data sets, many of which were not identified as significant before. Radiogenomics analysis revealed that a prognostic radiomic signature, capturing intra-tumour heterogeneity, was associated with underlying gene-expression patterns. These data suggest that radiomics identifies a general prognostic phenotype existing in both lung and head-and-neck cancer. This may have a clinical impact as imaging is routinely used in clinical practice, providing an unprecedented opportunity to improve decision-support in cancer treatment at low cost.

The dataset described here (Lung3) was used to investigate the association of radiomic imaging features with gene-expression profiles. The Lung2 dataset used for training the radiomic biomarker and consisting of 422 NSCLC CT scans with outcome data can be found here: NSCLC-Radiomics. Other data sets in the Cancer Imaging Archive that were used in the same study published in Nature Communications: HEAD-NECK-RADIOMICS-HN1, NSCLC-Radiomics-Interobserver1, RIDER Lung CT Segmentation Labels from: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach (RIDER-LungCT-Seg).

For scientific or other inquiries about this dataset, please contact TCIA's Helpdesk.